TT was previously found to be an activator of Protein Kinase C (PKC) isoforms, and a single intratumoral dose of TT caused hemorrhagic necrosis and tumor ablation in melanoma, HNSCC and other mouse models of cancer16,17. Here, PRRT2 is linked to neoplasm.